Michael J Fox Foundation awards $2 million to Parkinson’s apathy treatment
Drug Discovery World
JANUARY 3, 2024
Swedish company IRLAB Therapeutics has been awarded funding of over $2 million from The Michael J Fox Foundation for Parkinson’s Research (MJFF). The grant will be used to conduct a Phase I clinical study of IRL757, a drug candidate in development as a novel treatment of apathy. The grant was awarded under MJFF’s program ‘Parkinson’s Disease Therapeutics Pipeline Program.
Let's personalize your content